|
|
The analysis of management of dyslipidemia by outpatients in 2002-2007
Lancmannová, Lenka ; Vlček, Jiří (advisor) ; Malý, Josef (referee)
The analysis of managment of dyslipidemia by outpatients in 2002 - 2007 Student: Lenka Lancmannová Dissertation supervisit: Prof. RNDr. Jiří Vlček, CSc Training Specialist: Mgr. Martin Doseděl Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec kralove, Charles University in Prague, Czech Republic Introduction: Atherosclerosis and the resulting cardiovascular disease (ICHS, IM, ICHDK, CMP) are the main cause of morbidity and mortality of adult population in developed countries. The introduction of lipid lowering medicaments in clinical practice is one of the most therapeutic procedures affecting the prognosis and quality of life of patients Aim: Monitoring during treatment of patients with dyslipidemia, standardization of lipid levels, achieving the targets in the blood lipid levels. Monitoring prescription lipid lowering in the years 2002-2007 Methods: 177 patients were monitored (92 men, 85 women, average age 59 years) in the form of retrospectives, the period of 5 years. Data were drawn from the records from 3 patients of general practitioners and 1 internists. Results: The largest representation of patients have the mixed dyslipidemia, 91%. Most patients fell within the primary prevention of 54,2%, in secondary prevention 28.8% in secondary prevention with DM2 type 6.2%,...
|
|
|
The analysis of management of dyslipidemia by outpatients in 2002-2007
Lancmannová, Lenka ; Vlček, Jiří (advisor) ; Malý, Josef (referee)
The analysis of managment of dyslipidemia by outpatients in 2002 - 2007 Student: Lenka Lancmannová Dissertation supervisit: Prof. RNDr. Jiří Vlček, CSc Training Specialist: Mgr. Martin Doseděl Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec kralove, Charles University in Prague, Czech Republic Introduction: Atherosclerosis and the resulting cardiovascular disease (ICHS, IM, ICHDK, CMP) are the main cause of morbidity and mortality of adult population in developed countries. The introduction of lipid lowering medicaments in clinical practice is one of the most therapeutic procedures affecting the prognosis and quality of life of patients Aim: Monitoring during treatment of patients with dyslipidemia, standardization of lipid levels, achieving the targets in the blood lipid levels. Monitoring prescription lipid lowering in the years 2002-2007 Methods: 177 patients were monitored (92 men, 85 women, average age 59 years) in the form of retrospectives, the period of 5 years. Data were drawn from the records from 3 patients of general practitioners and 1 internists. Results: The largest representation of patients have the mixed dyslipidemia, 91%. Most patients fell within the primary prevention of 54,2%, in secondary prevention 28.8% in secondary prevention with DM2 type 6.2%,...
|
guest ::
